Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia

PURPOSE: To assess the clinical and economic outcomes among patients with chemotherapy-induced anemia (CIA) treated with United States Food and Drug Administration-approved fixed dosing regimens of erythropoiesis-stimulating agents (ESA). METHODS: Data were employed from the Dosing and Outcomes Stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Pashos, Chris L., Larholt, Kay, Fraser, Kimberly A., McKenzie, R. Scott, Senbetta, Mekré, Piech, Catherine Tak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223590/
https://www.ncbi.nlm.nih.gov/pubmed/21359879
http://dx.doi.org/10.1007/s00520-010-1083-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223590/
https://www.ncbi.nlm.nih.gov/pubmed/21359879
http://dx.doi.org/10.1007/s00520-010-1083-7

Ejemplares similares